How should I empirically manage an older patient with chronic baseline confusion who retains decision‑making capacity and refuses referral for dyspeptic symptoms and crampy abdominal pain?

Management of Dyspepsia in an Older Patient with Baseline Confusion Who Refuses Referral

In an older patient with chronic baseline confusion who retains decision-making capacity and refuses referral, you should proceed with empirical management starting with non-invasive H. pylori testing followed by eradication therapy if positive, or empirical acid suppression with a PPI if negative, while respecting their autonomous refusal of endoscopy. 1

Respecting Autonomy While Managing Risk

The patient's baseline confusion does not negate their decision-making capacity if they can understand and communicate their preferences. The 2019 AGS guidelines on multimorbidity emphasize that decision-making must be filtered through patients' health outcome goals and healthcare preferences, even when uncertainty exists 2. Your role is to work within their stated preferences while minimizing harm and treatment burden.

Age-Appropriate Risk Stratification

This patient's age matters significantly for risk assessment:

• If ≥60 years with abdominal pain and weight loss: The BSG guidelines strongly recommend urgent abdominal CT to exclude pancreatic cancer 1
• If ≥55 years with dyspepsia and weight loss: Urgent endoscopy is warranted 1
• If ≥55 years with treatment-resistant dyspepsia, raised platelet count, nausea, or vomiting: Non-urgent endoscopy should be considered 1

However, since the patient refuses referral and retains capacity, you cannot force investigation. Document their refusal carefully and explain the risks they are accepting.

Empirical Management Algorithm

Step 1: Initial Testing and Treatment

Test for H. pylori using non-invasive methods (stool antigen or urea breath test):

• If positive: Provide eradication therapy 1
• If negative or symptoms persist after eradication: Proceed to Step 2

Step 2: Empirical Acid Suppression

Offer empirical PPI therapy at standard dose for 4-8 weeks 1, 3. This is a strong recommendation with high-quality evidence for patients without H. pylori infection 1.

• Do not escalate to higher PPI doses if standard dosing fails—this is ineffective 4
• If symptoms persist after 2-4 weeks, consider changing drug class (e.g., H2-receptor antagonist) 3

Step 3: Consider Prokinetics for Specific Symptoms

If the patient has predominantly postprandial fullness or early satiation (postprandial distress syndrome), a short course of prokinetic therapy may be appropriate 4. However, prokinetics are not recommended as first-line therapy 1.

Step 4: Neuromodulators for Refractory Symptoms

If acid suppression fails and the patient has predominantly epigastric pain, consider tricyclic antidepressants (low-dose) 3, 4. For patients with weight loss, mirtazapine may be beneficial 4.

Critical Safety Considerations

Alarm Features That Demand Reassessment

Even with patient refusal, you must repeatedly assess for and document:

• Weight loss (triggers need for imaging/endoscopy)
• Dysphagia
• Persistent vomiting
• Anemia or GI bleeding
• Raised platelet count

If any develop, re-engage the patient about investigation, emphasizing the changed risk-benefit calculation. Document each conversation.

Medication Safety in Older Adults with Confusion

The patient's baseline confusion increases risks:

• Drug interactions: Review all medications carefully before adding PPIs or other agents
• Compliance concerns: Simplify regimens when possible 5
• Cognitive effects: TCAs can worsen confusion—use lowest effective doses and monitor closely 3

Baseline Laboratory Work

Obtain a full blood count to screen for anemia and check platelet count 1. If the patient has overlapping bowel symptoms, consider celiac serology 1.

Common Pitfalls to Avoid

1. Do not pursue routine gastric emptying studies or 24-hour pH monitoring—these are not recommended for typical FD symptoms 1

2. Do not use restrictive diets—there is no evidence for specialized diets in FD, and restriction risks malnutrition in older adults 1, 4

3. Do not assume confusion negates capacity—assess decision-making ability specifically for this decision 2, 6

4. Do not abandon the patient—establish regular follow-up to reassess symptoms, monitor for alarm features, and revisit the discussion about investigation if clinical circumstances change 1

Documentation Strategy

Given the patient's refusal of appropriate investigation:

• Document their understanding of risks (malignancy, other serious pathology)
• Document their capacity to make this decision
• Document your recommendations and their specific refusal
• Schedule defined follow-up intervals to reassess

When Empirical Management Fails

If symptoms remain refractory to empirical therapy, the BSG guidelines note that endoscopy is not mandatory but should be reconsidered based on clinical judgment 1. At this point, re-engage the patient about specialist referral, emphasizing that you've exhausted reasonable empirical options and that quality of life may improve with definitive diagnosis.

The goal is to balance respect for autonomy with your duty to prevent morbidity and mortality, working within the constraints the patient has set while keeping the door open for reconsideration as circumstances evolve.